The use of Zepbound KwikPen beyond the 30-day in-use period is not recommended.

Lilly’s in-use period testing of the KwikPen ensured that the medicine met certain quality standards from first use of the Zepbound KwikPen to the fourth dose injection.

The in-use period testing of the Zepbound KwikPen was sufficient to support an in-use period of 30 days.

style
background-none
additionalPadding
narrow
Eli Lilly and Company cannot provide treatment recommendations for the use of Zepbound KwikPen beyond the 30-days in-use period.
Back to Zepbound KwikPen Main Page
style
background-primary-red
additionalPadding
narrow
additionalMargin
narrow
roundedBorders
true

Reference

  1. Data on File. Eli Lilly and its subsidiaries
style
background-none
additionalPadding
narrow
style
background-primary-red
additional-link, ctaselection-link, ctatarget-newtab, ctaexitinterstitial-select
How to dispose Zepbound KwikPen
style
background-primary-red, two-col-50-50
extra-styles
offset
VV-Canada Medical-US-DEL-0347 06/2025
style
background-primary-red
additionalPadding
narrow